Carried out 200% honest trials, don't deserve this backlash: Bharat Biotech hits back at critics

Some opposition leaders and scientific researchers criticised Covaxin for being given emergency use authorisation without completion of phase 3 trials

from Latest News https://www.dnaindia.com/india/report-carried-out-200-percent-honest-trials-dont-deserve-this-backlash-bharat-biotech-hits-back-at-critics-2866021